Ifp Advisors, Inc Myriad Genetics Inc Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 584 shares of MYGN stock, worth $4,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares

584

Previous 164 256.1%

Holding current value

$4,777

Previous $1,000 200.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$3.84 - $8.84 $1,612 - $3,712	420 Added 256.1%	584 $3,000
Q1 2025 May 05, 2025	BUY	$8.87 - $14.98 $1,357 - $2,291	153 Added 1390.91%	164 $1,000
Q4 2024 Feb 04, 2025	BUY	$13.17 - $27.03 $144 - $297	11 New	11 $0
Q3 2021 Oct 06, 2021	SELL	$29.97 - $36.66 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$25.39 - $32.61 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$19.92 - $31.6 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$12.16 - $19.77 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$11.25 - $14.75 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$10.69 - $16.49 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	SELL	$9.78 - $29.53 $146 - $442	-15 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$20.93 - $35.1 $313 - $526	15 New	15 $0
Q3 2019 Nov 07, 2019	BUY	$22.08 - $47.08 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $6,059 - $7,807	-225 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$27.23 - $45.56 $50,892 - $85,151	-1,869 Reduced 89.26%	225 $6,000
Q3 2018 Oct 25, 2018	BUY	$37.57 - $50.34 $5,071 - $6,795	135 Added 6.89%	2,094 $0
Q2 2018 Aug 07, 2018	BUY	$27.75 - $40.17 $20,118 - $29,123	725 Added 58.75%	1,959 $0
Q1 2018 Jun 03, 2019	SELL	$28.83 - $41.01 $14,703 - $20,915	-510 Reduced 29.24%	1,234 $42,000
Q1 2018 May 09, 2018	BUY	$28.83 - $41.01 $14,703 - $20,915	510 Added 41.33%	1,744 $0
Q4 2017 Jan 24, 2018	BUY	$28.45 - $37.14 $19,488 - $25,440	685 Added 124.77%	1,234 $0
Q3 2017 Oct 30, 2017	BUY	$24.01 - $36.2 $8,403 - $12,670	350 Added 175.88%	549 $20,000
Q2 2017 Jun 03, 2019	SELL	N/A	-41 Reduced 17.08%	199 $5,000
Q4 2016 Jun 03, 2019	SELL	N/A	-630 Reduced 72.41%	240 $4,000
Q2 2016 Jun 03, 2019	BUY	N/A	870	870 $27,000

Others Institutions Holding MYGN

# of Institutions

235

Shares Held

95.5M

Call Options Held

460K

Put Options Held

14.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $660M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account